About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Metropolis Healthcare Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
05-May-2025
13-May-2025
Audited Results
29-Jan-2025
04-Feb-2025
Quarterly Results
05-Dec-2024
09-Dec-2024
Preferential Issue of shares Inter-alia to consider and approve the following: 1. Issuance of equity shares of the Company on a preferential basis, in accordance with the applicable laws, subject to the approval of shareholders of the Company and such other statutory approvals, as may be required. 2. Postal ballot notice for seeking shareholders approval in respect of the aforesaid proposal, if approved by the Board.
30-Oct-2024
08-Nov-2024
Quarterly Results
05-Aug-2024
10-Aug-2024
Quarterly Results
14-May-2024
21-May-2024
Audited Results
29-Jan-2024
02-Feb-2024
Quarterly Results
30-Oct-2023
04-Nov-2023
Quarterly Results & Interim Dividend
27-Jul-2023
02-Aug-2023
Quarterly Results
17-May-2023
16-May-2023
Audited Results(Cancelled)
10-May-2023
16-May-2023
Audited Results
06-Feb-2023
10-Feb-2023
Quarterly Results & Interim Dividend
31-Oct-2022
08-Nov-2022
Quarterly Results
04-Aug-2022
10-Aug-2022
Quarterly Results
12-Jul-2022
18-Jul-2022
Inter alia, to consider and approve the revised Audited Standalone Financial results of the Company for the Quarter and Year ended March 31,2022 after taking on record the amalgamation of the 8(Eight) wholly owned Subsidiary Companies with the Company.
16-May-2022
24-May-2022
Audited Results
03-Feb-2022
11-Feb-2022
Quarterly Results & Interim Dividend
03-Nov-2021
10-Nov-2021
Quarterly Results
02-Aug-2021
06-Aug-2021
Quarterly Results & Inter alia, to consider and approve Proposal for raising funds either by way of private placement or preferential issue or public issue or through any other permissible mode and/or combination thereof, including by way of Qualified Institutions Placement, in accordance with applicable laws; and other matters
21-May-2021
27-May-2021
Audited Results
Page
1
of
2
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.